<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="366147">
  <stage>Registered</stage>
  <submitdate>14/04/2014</submitdate>
  <approvaldate>29/04/2014</approvaldate>
  <actrnumber>ACTRN12614000431628</actrnumber>
  <trial_identification>
    <studytitle>Dietary fructose consumption and cardio-metabolic health </studytitle>
    <scientifictitle>Dietary fructose increases blood lipids and inflammation and reduces insulin response and satiety hormones in healthy volunteers.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>NIL</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cardio-metabolic Health</healthcondition>
    <healthcondition>Metabolic-Syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Metabolic disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>A dietary intervention acute trial will be conducted in healthy subjects, in randomized controlled cross-over design. Acute trial will involve dietary intervention with a single dose of sugar (fructose/glucose/sucrose) sweetened drink followed by collection of blood samples at 0, 30, 60, and 120 minutes following consumption of a) lemon-flavoured drink containing 50g of fructose, b) lemon-flavoured drink containing 50g of glucose and c) lemon flavoured drink containing 50g of sucrose. After a 1 week period of wash out the experiment will be repeated swapping groups. Subjects will be asked to fill a medical and a physical activity questionnaire and will have their anthropometric measurements taken. In addition, subjects will complete a 24 hour food record.</interventions>
    <comparator>Sucrose</comparator>
    <control>Active</control>
    <interventioncode>Lifestyle</interventioncode>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To examine the acute effects of fructose consumption on:
Blood Lipids
</outcome>
      <timepoint>At base line, 30, 60 and 120 minutes</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>To examine the acute effects of fructose consumption on:
Satiety Hormones

This outcome will be analysed by blood serum assays</outcome>
      <timepoint>At baseline, 30, 60 and 120 minutes</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>To examine the acute effects of fructose consumption on:
Inflammatory Bio-markers (hs-CRP)

This outcome will be analysed by blood serum assays</outcome>
      <timepoint>At baseline, 30, 60 and 120 minutes</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To examine the acute effects of fructose consumption on:
Insulin Resistance

This outcome will be analysed by blood serum assays</outcome>
      <timepoint>At baseline, 30, 60 and 120 minutes</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy male or female.
Are aged above 18 years at initial assessment
</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Currently on cholesterol lowering drugs
Currently on non-steroidal anti-inflammatory drugs
Currently on fructose/sugar restricted diet
Currently on weight loss program
Have a body mass index (BMI) greater than 30
Diagnosed with any gastrointestinal disorder
Diabetes
Pregnancy or lactation
Vegan diet
Undergone any surgical procedure for obesity
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>A randomised controlled, dietary intervention trial, in a cross-over design. Participants will be recruited by advertisement in newspaper and radio interviews as well as from the HMRI register of volunteers. Allocation is not concealed.</concealment>
    <sequence>Block randomization</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures>NIL</designfeatures>
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>12/03/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate>24/06/2013</actualenddate>
    <samplesize>14</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <postcode>2308 - Newcastle University</postcode>
    <postcode>2308 - Callaghan</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>The UNiversity of Newcastle</primarysponsorname>
    <primarysponsoraddress>University Drive
Callaghan
NSW 2308</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Hunter Medical Research Institute (HMRI)</fundingname>
      <fundingaddress>1/Kookaburra Circuit, 
New Lambton Heights,
 NSW 2305</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Other</sponsortype>
      <sponsorname>Hunter Medical Research Institute (HMRI)</sponsorname>
      <sponsoraddress>1/Kookaburra Circuit, 
New Lambton Heights,
 NSW 2305</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>There is evidence in the published literature that consumption of a high fructose diet is detrimental to cardio-metabolic health. The purpose of this research is to determine the effect of dietary fructose consumption on plasma lipids, satiety hormones, insulin resistance and inflammation. If our hypothesis is validated, dietary strategies can be designed to reduce body weight and associated risk for the development of diabetes and cardiovascular disease</summary>
    <trialwebsite />
    <publication>Faizan Jameel Nov 2013
Presented at Australasian Section of AOCS
06-08 November 2013, Newcastle,  Australia

Faizan Jameel Dec 2013
Presented at Annual Scientific Meeting of The Nutrition Society of Australia, in conjunction with The Nutrition Society Of New Zealand, 
04-06 December 2013, Brisbane, Australia</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The University of Newcastle Human Ethics Committee</ethicname>
      <ethicaddress>Research Office, The Chancellery, The University of Newcastle, University Drive, Callaghan, NSW 2308</ethicaddress>
      <ethicapprovaldate>6/08/2012</ethicapprovaldate>
      <hrec>H-2011-0336</hrec>
      <ethicsubmitdate>22/05/2012</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment>
    <filepath>http://www.anzctr.org.au/AnzctrAttachments/366147-Proceedings of the 2013 Meeting of the Australasian Section of the American Oil Chemists Society (AOCS).pdf</filepath>
  </attachment>
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Manohar Garg</name>
      <address>MS305C, School of Biomedical Sciences and Pharmacy, The University of Newcastle University Drive, Callaghan, NSW 2308

</address>
      <phone>+ 61 2 4921 5647</phone>
      <fax>+ 61 2 4921 2028</fax>
      <email>Manohar.Garg@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Faizan Jameel</name>
      <address>MS305B, School of Biomedical Sciences and Pharmacy, The University of Newcastle University Drive, Callaghan, NSW 2308</address>
      <phone>+ 61 2 4921 5638</phone>
      <fax />
      <email>Faizan.Jameel@uon.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Manohar Garg</name>
      <address>MS305C, School of Biomedical Sciences and Pharmacy, The University of Newcastle University Drive, Callaghan, NSW 2308</address>
      <phone>+ 61 2 4921 5647</phone>
      <fax>+ 61 2 4921 5647</fax>
      <email>Manohar.Garg@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Faizan Jameel</name>
      <address>MS305B, School of Biomedical Sciences and Pharmacy, The University of Newcastle University Drive, Callaghan, NSW 2308</address>
      <phone>+ 61 2 4921 5638</phone>
      <fax />
      <email>Faizan.Jameel@uon.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>